Medical Properties Trust (NYSE:MPW) was upgraded by equities research analysts at J P Morgan Chase & Co from an “underweight” rating to a “neutral” rating in a research report issued to clients and investors on Friday.

Several other research analysts have also issued reports on the stock. Jefferies Group reaffirmed a “buy” rating and issued a $15.00 target price on shares of Medical Properties Trust in a research note on Tuesday, August 29th. ValuEngine lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Zacks Investment Research lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. SunTrust Banks reissued a “buy” rating and set a $15.00 price objective on shares of Medical Properties Trust in a research note on Friday, November 3rd. Finally, KeyCorp reissued a “hold” rating on shares of Medical Properties Trust in a research note on Sunday, September 17th. Seven analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $14.18.

Shares of Medical Properties Trust (NYSE:MPW) opened at $13.76 on Friday. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.55 and a quick ratio of 2.55. The firm has a market cap of $5,029.00, a PE ratio of 10.70, a price-to-earnings-growth ratio of 1.84 and a beta of 0.96. Medical Properties Trust has a 1 year low of $11.89 and a 1 year high of $14.22.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.01. The firm had revenue of $176.60 million during the quarter, compared to analysts’ expectations of $172.57 million. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The company’s quarterly revenue was up 39.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.30 EPS. equities research analysts forecast that Medical Properties Trust will post 1.32 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Principal Financial Group Inc. increased its holdings in Medical Properties Trust by 142.8% during the second quarter. Principal Financial Group Inc. now owns 11,859,196 shares of the real estate investment trust’s stock worth $152,628,000 after buying an additional 6,973,902 shares during the last quarter. Prudential Financial Inc. increased its holdings in Medical Properties Trust by 766.7% during the second quarter. Prudential Financial Inc. now owns 4,320,798 shares of the real estate investment trust’s stock worth $55,608,000 after buying an additional 3,822,244 shares during the last quarter. Vanguard Group Inc. increased its holdings in Medical Properties Trust by 6.6% during the second quarter. Vanguard Group Inc. now owns 57,790,855 shares of the real estate investment trust’s stock worth $743,768,000 after buying an additional 3,561,518 shares during the last quarter. Systematic Financial Management LP acquired a new position in Medical Properties Trust during the second quarter worth $29,018,000. Finally, Bank of New York Mellon Corp increased its holdings in Medical Properties Trust by 9.5% during the third quarter. Bank of New York Mellon Corp now owns 14,803,927 shares of the real estate investment trust’s stock worth $194,375,000 after buying an additional 1,278,480 shares during the last quarter. Institutional investors own 81.35% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Daily Political and is owned by of Daily Political. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.dailypolitical.com/2017/12/15/medical-properties-trust-mpw-upgraded-to-neutral-at-j-p-morgan-chase-co.html.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.